The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.
When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision. The group at the time was ...
Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...
Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.
Q3 2025 Earnings Call Feb 18, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.
Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.
In a news release, CEO Geoff Martha said, “Thierry is a strategic, creative, operationally focused, experienced CFO with a proven track record of delivering innovation-driven growth, margin ...
Reports Q3 revenue $8.29B, consensus $8.33B. “We delivered strong earnings this quarter, with significant improvements in both our gross margin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results